Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-01-11
2011-01-11
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S577000, C514S725000, C514S859000
Reexamination Certificate
active
07868044
ABSTRACT:
Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.
REFERENCES:
patent: 4717720 (1988-01-01), Shroot et al.
patent: 5098895 (1992-03-01), Shroot et al.
patent: 5212303 (1993-05-01), Shroot et al.
patent: RE34440 (1993-11-01), Shroot et al.
patent: 5306486 (1994-04-01), McCook et al.
patent: 5603940 (1997-02-01), Candau et al.
patent: 5665364 (1997-09-01), McAtee et al.
patent: 6383505 (2002-05-01), Kaiser et al.
patent: 6413536 (2002-07-01), Gibson et al.
patent: 7083799 (2006-08-01), Giacomoni
patent: 7597377 (2009-08-01), Graeber et al.
patent: 7642288 (2010-01-01), Graeber
patent: 2005/0059740 (2005-03-01), Graeber et al.
patent: 0 199 636 (1986-10-01), None
patent: 0 487 973 (1996-03-01), None
patent: 0 487 973 (1996-03-01), None
patent: 2 730 930 (1996-08-01), None
patent: WO 02/083086 (2002-10-01), None
patent: WO 03/075908 (2003-09-01), None
“Topical Formulary for Carbopol® Polymers”, Noveon, Inc., The Specialty Chemicals Innovator, Pharmaceutical Polymers, pp. 1-25, Jan. 2002, Cleveland, Ohio.
Body Cream, Phytosan™ , Formula No. 416.09.0077, 2008.
Jamoulle et al., “Follicular Penetration and Distribution of Topically Applied CD 271, a new Naphthoic Acid Derivative Intended for Topical Acne Treatment”,Journal of Investigative Dermatology, (1990), 94(5), 731-732, published by Nature Publishing Group.
Allec et al., “Skin distribution and pharmaceutical aspects of adapalene gel,”J. Am. Acad. Dermatol.(1997) 36:S119-S125, published by American Academy of Dermatology, Inc., US.
Shroot et al., “A New Concept of Drug Delivery for Acne”,Dermatology(1998), 196:165-170, published by S. Karger AG, Switzerland.
Rolland et al., “Site-specific Drug Delivery to Pilosebaceous Structures Using Polymeric Microspheres”,Pharmaceutical Research(1993), vol. 10, No. 12, 1738-1744, published by Plenum Publishing Corporation.
Alirezai et al., “Etude Comparative de l'efficacité et de la tolérance de gels d'adapalène à 0,1 et 0,03 p 100 et d'un gel de trétimoïne á 0,025 p 100 dans le traitement de l'acné” (Effićacy and safety comparison study of 0.1 p 100 and 0.03 p 100 adapalene gels and tretinoin gel in the topical treatment of acne),Ann. Dermatol. Venereol. (1996), 123:165-170, published by Paris Masson, Paris, France.
Healy et al. “Acnevulgaris”,British Medical Journal, 1994 vol. 308, Iss. 6932, pp. 2-9.
Czernielewski et al. “Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne”,Journal of European Academy of Dermatology and Venerology, Dec. 2001, vol. 15, Supplement 3, pp. 5-12.
Differen Gel Data Sheet, available Nov. 1998, pp. 1-5.
Goldfarb et al., “Photographic assessment of the effects of adapalene 0.1% and 0.3% gels and vehicle in photodamaged skin,” Abstract published in European Academy of Dermatology and Venereology JEADV (2000) 14 (Suppl. 1), 315, Wiley-Blackwell, Hoboken, New Jersey.
Kang et al. “Assessment of Adapalene gel for the treatment of actinic keratoses and lentigines: A randomized trial,” J. Am. Acad. Dermatol., Jul. 2003, pp. 83-90, American Academy of Dermatology, Inc., Schaumberg, Illinois.
Talukdar et al. Journal of Pharmaceutical Sciences, May 1996, vol. 85, No. 5, pp. 537-540.
Seppicontrol, A5, Aug. 2001, pp. 1-53.
International Search Report for corresponding PCT/EP03/03246, (WO 03/075908 A1), in English.
Protest Under 37 C.F.R. § 1.291 regarding U.S. Appl. No. 11/494,693 (US 2007/0043119) with attachments dated Jun. 14, 2008.
European Search Report for corresponding European Application EP 05 003144 (in English).
Minutes for Oral Proceedings for European Application EP 03712109 corresponding to parent U.S. Appl. No. 10/937,612.
File History of U.S.P. 5,098,895 Shroot et al.
File History of Reissue 34,440, Shroot et al.
Notification of Non-entry of Protest, dated Aug. 29, 2008, in U.S. Appl. No. 11/494,693 filed Jul. 28, 2006.
Czernielewski Janusz
Graeber Michael
Buchanan & Ingersoll & Rooney PC
Galderma Research & Development
Jean-Louis Samira
Padmanabhan Sreeni
LandOfFree
Method for the treatment of acne using compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of acne using compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of acne using compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701547